These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 412104)

  • 1. Preclinical toxicology protocols of the Laboratory of Toxicology.
    Prieur DJ; Young DM; Davis RD; Cooney DA; Guarino AM
    Natl Cancer Inst Monogr; 1977 Mar; (45):159-77. PubMed ID: 412104
    [No Abstract]   [Full Text] [Related]  

  • 2. Procedures for preclinical toxicologic evaluation of cancer chemotherapeutic agents: protocols of the laboratory of toxicology.
    Prieur DJ; Young DM; Davis RD; Cooney DA; Homan ER; Dixon RL; Guarino AM
    Cancer Chemother Rep 3; 1973 Jan; 4(1):1-39. PubMed ID: 4634117
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxicology of anticancer drugs.
    Guarino AM
    Natl Cancer Inst Monogr; 1977 Mar; (45):49-55. PubMed ID: 412105
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S; Wittes R
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract]   [Full Text] [Related]  

  • 5. [Introduction of new screening system in National Cancer Institute].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1984 May; 11(5):1134-9. PubMed ID: 6539100
    [No Abstract]   [Full Text] [Related]  

  • 6. [Models and methods used for the selection of antitumor preparations in the USSR and abroad].
    Sof'ina ZP
    Vopr Onkol; 1976; 22(4):82-96. PubMed ID: 1274284
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening at the National Cancer Institute.
    Goldin A; Venditti JM; Carter SK
    Natl Cancer Inst Monogr; 1977 Mar; (45):37-48. PubMed ID: 337155
    [No Abstract]   [Full Text] [Related]  

  • 8. The preclinical new drug research program of the National Cancer Institute.
    Driscoll JS
    Cancer Treat Rep; 1984 Jan; 68(1):63-76. PubMed ID: 6692438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.
    Goldsmith MA; Slavik M; Carter SK
    Cancer Res; 1975 May; 35(5):1354-64. PubMed ID: 804350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary.
    Venditti JM
    Cancer Treat Rep; 1983 Sep; 67(9):767-72. PubMed ID: 6883352
    [No Abstract]   [Full Text] [Related]  

  • 11. Relation of preclinical toxicology to findings in early clinical trials.
    Grieshaber CK; Marsoni S
    Cancer Treat Rep; 1986 Jan; 70(1):65-72. PubMed ID: 3943115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical toxicology of anticancer agents.
    Schein PS
    Cancer Res; 1977 Jun; 37(6):1934-7. PubMed ID: 404039
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli.
    Charles LM; Bono VH
    Cancer Treat Rep; 1981; 65 Suppl 4():39-46. PubMed ID: 7049380
    [No Abstract]   [Full Text] [Related]  

  • 14. Preclinical toxicology studies with ICRF-159 (NSC-129943)--a new antineoplastic drug.
    Gralla EJ; Coleman GL; Jonas AM
    Cancer Chemother Rep 3; 1974 Sep; 5(1):1-7. PubMed ID: 4213305
    [No Abstract]   [Full Text] [Related]  

  • 15. Preclinical toxicologic evaluation of tetrahydrouridine (NSC-112907) in beagle dogs and rhesus monkeys.
    Goldenthal EI; Cookson KM; Geil RG; Wazeter FX
    Cancer Chemother Rep 3; 1974 Sep; 5(1):15-6. PubMed ID: 4213302
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological properties and antitumor activity of a preparation diiodo-benzo-tepa in experiments].
    Trinus FP; Sologub PY; Protsenko LD; Tarnavskaya MI; Nikolaeva SV; Danilenko VS; Sharykina NI; Kolodyazhny VI; Zaikina RG; Goncharenko GV; Kopel'nik MA; Andrianova SM
    Vopr Onkol; 1979; 25(9):53-8. PubMed ID: 90429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The linear array.
    Zubrod CG; Schepartz SA; Carter SK
    Natl Cancer Inst Monogr; 1977 Mar; (45):13-4. PubMed ID: 927488
    [No Abstract]   [Full Text] [Related]  

  • 18. Preclinical toxicology of alpha-2'-deoxythioguanosine (NSC-71851).
    Henry MC; DiDomenico E
    Cancer Chemother Rep 3; 1974 Sep; 5(1):9-14. PubMed ID: 4213304
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Anticancer drug development programs: a comparison of approaches in the United States, the Soviet Union, Japan, and Western Europe.
    Carter SK
    Natl Cancer Inst Monogr; 1974 Feb; 40():31-45. PubMed ID: 4819407
    [No Abstract]   [Full Text] [Related]  

  • 20. Modified protocol for the testing of new synthetics in the L1210 lymphoid leukemia murine model in the DR&D program, DCT, NCI.
    Geran RI; Greenberg NH; Macdonald MM; Abbott BJ
    Natl Cancer Inst Monogr; 1977 Mar; (45):151-3. PubMed ID: 927490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.